About PHC Holdings
PHC Holdings is a company based in Minato (Japan) founded in 1969 was acquired by KKR in September 2013. PHC Holdings has raised $182.35 million across 1 funding round from investors including KKR and L Catterton. The company has 9,040 employees as of March 31, 2024. PHC Holdings has completed 3 acquisitions, including Fujifilm, MM France and SciMed. PHC Holdings offers products and services including Glucose Monitoring Systems, Clinical Testing Services, and Electronic Medical Record Systems. PHC Holdings operates in a competitive market with competitors including Cepheid, Beckman Coulter, Bruker, Blackrock Neurotech and Esco Lifesciences, among others.
- Headquarter Minato, Japan
- Employees 9040 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Phc Holdings Corp.
-
Annual Revenue
$2.42 B (USD)2.17as on Mar 31, 2025
-
Net Profit
$70.13 M (USD)0as on Mar 31, 2025
-
EBITDA
$333.19 M (USD)37.37as on Mar 31, 2025
-
Total Equity Funding
$182.35 M (USD)
in 1 rounds
-
Latest Funding Round
$182.35 M (USD), Series D
Mar 30, 2021
-
Investors
KKR
& 1 more
-
Employee Count
9040
as on Mar 31, 2024
-
Investments & Acquisitions
Fujifilm
& 2 more
-
Acquired by
KKR
(Sep 27, 2013)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of PHC Holdings
PHC Holdings is a publicly listed company on the TSE with ticker symbol 6523 in Japan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of PHC Holdings
PHC Holdings offers a comprehensive portfolio of products and services, including Glucose Monitoring Systems, Clinical Testing Services, and Electronic Medical Record Systems.
Devices for monitoring blood glucose levels in patients
Services supporting illness prevention and treatment through testing
Systems for managing patient records and prescriptions
People of PHC Holdings
Unlock access to complete
Funding Insights of PHC Holdings
PHC Holdings has successfully raised a total of $182.35M through 1 strategic funding round. The most recent funding activity was a Series D round of $182.35 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in PHC Holdings
PHC Holdings has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include KKR and L Catterton.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
L Catterton is recognized as a leading consumer-focused private equity group.
|
Locked | Locked | Locked | |
|
Multiple sectors are invested in by this private equity firm.
|
Locked | Locked | Locked |
Investor details for PHC Holdings
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PHC Holdings
PHC Holdings has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Fujifilm, MM France and SciMed.
Investment portfolio details for PHC Holdings
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of products and services for biomedical, education, healthcare, industrial laboratory and life sciences sector
|
Locked | Locked | 1992 | Locked | |
|
Medical consumables, stainless steel, and instruments are manufactured and supplied.
|
Locked | Locked | 1987 | Locked | |
|
Multiple sectors are invested in by the venture capital firm.
|
Locked | Locked | 1934 | Locked |
Complete acquisition details for PHC Holdings
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - PHC Holdings
Detailed financials for PHC Holdings
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Phc Holdings Comparisons
Peer comparison for PHC Holdings
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PHC Holdings
PHC Holdings operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cepheid, Beckman Coulter, Bruker, Blackrock Neurotech and Esco Lifesciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of molecular diagnostic testing solutions
|
|
| Locked | Locked | Locked |
Provider of products for biomedical testing for R&D, diagnostic and commercial applications
|
|
| Locked | Locked | Locked |
Diversified research instrument systems are manufactured and supplied.
|
|
| Locked | Locked | Locked |
Medical devices for neurological therapies are developed.
|
|
| Locked | Locked | Locked |
Manufacturer of biopharma equipment & IVF medical devices, and service provider for life science tools
|
|
| Locked | Locked | Locked |
Multiplex protein stability platform for biologics is developed.
|
Detailed competitors of PHC Holdings
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Phc Holdings
Complete news archive for PHC Holdings
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PHC Holdings
PHC Holdings was founded in 1969 and raised its 1st funding round 52 years after it was founded.
PHC Holdings is headquartered in Minato, Japan. It is registered at Minato, Tokyo, Japan.
Hidehito Kotani is the current CEO of PHC Holdings.
PHC Holdings is a funded company, having raised a total of $182.35M across 1 funding round to date.
As of Mar 31, 2024, the latest employee count at PHC Holdings is 9,040.
Annual revenue of PHC Holdings is $2.42B as on Mar 31, 2025.
PHC Holdings was founded in 1969 and is headquartered in Minato City, Japan. Devices and services for life science research are supplied by the company within the healthcare and life sciences sector. Test analysis devices, healthcare IT solutions, and instruments for the life sciences industry are developed. Drug delivery solutions and medical record systems are also provided to support research and operational needs.
PHC Holdings's top competitors include Cepheid, Blackrock Neurotech and Esco Lifesciences.
PHC Holdings offers Glucose Monitoring Systems, Clinical Testing Services, and Electronic Medical Record Systems.
Yes, PHC Holdings is publicly traded on TSE under the ticker symbol 6523.
PHC Holdings has 2 investors. Key investors include KKR, and L Catterton.
The ticker symbol of PHC Holdings is 6523 on TSE.